Gun Anker
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
- Co-authors
- Per Eystein Lønning (24 shared papers)Jürgen Geisler (6 shared papers)Mitch Dowsett (3 shared papers)Ben P. Haynes (2 shared papers)Ernst A. Lien (9 shared papers)Per Magne Ueland (8 shared papers)E. Di Salle (3 shared papers)Nicholas King (1 shared paper)
- Journals
- European Journal of Cancer (4 papers)The Journal of Steroid Biochemistry and Molecular Biology (3 papers)Journal of Clinical Oncology (2 papers)PLoS ONE (2 papers)Annals of Oncology (2 papers)
- Partner nations
- NorwaySwedenUnited Kingdom
In The Last Decade
Gun Anker
37 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 723
- Oncology 1.0k
- Genetics 1.0k
- Endocrinology, Diabetes and Metabolism 228
- Reproductive Medicine 88
Countries citing papers authored by Gun Anker
This map shows the geographic impact of Gun Anker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gun Anker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gun Anker more than expected).
Fields of papers citing papers by Gun Anker
This network shows the impact of papers produced by Gun Anker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gun Anker. The network helps show where Gun Anker may publish in the future.
Co-authors
The 25 scholars most cited alongside Gun Anker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 454 | |
| 2 | In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. | 1998 | 270 |
| 3 | 2000 | 216 | |
| 4 | 2001 | 167 | |
| 5 | TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. | 2003 | 118 |
| 6 | 2010 | 106 | |
| 7 | 2006 | 97 | |
| 8 | 2002 | 87 | |
| 9 | 1995 | 86 | |
| 10 | 2011 | 81 | |
| 11 | Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide. | 1990 | 80 |
| 12 | 2008 | 76 | |
| 13 | 1995 | 65 | |
| 14 | 2012 | 58 | |
| 15 | 2012 | 56 | |
| 16 | 2000 | 50 | |
| 17 | 1996 | 50 | |
| 18 | 1998 | 29 | |
| 19 | 1998 | 28 | |
| 20 | 2007 | 27 |
About Gun Anker
Gun Anker is a scholar working on Oncology, Genetics, Endocrinology, Diabetes and Metabolism, Rheumatology and Cancer Research, having authored 38 papers that have together received 2.4k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (12 papers), Folate and B Vitamins Research (5 papers), Cancer Risks and Factors (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers), Cancer survivorship and care (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Cancer Research (723 citations), Oncology (1.0k citations), Genetics (1.0k citations), Endocrinology, Diabetes and Metabolism (228 citations) and Reproductive Medicine (88 citations). Gun Anker has collaborated with scholars based in Norway, Sweden and United Kingdom. Frequent co-authors include Per Eystein Lønning, Jürgen Geisler, Mitch Dowsett, Ben P. Haynes, Ernst A. Lien, Per Magne Ueland, E. Di Salle, Nicholas King, G. Ornati and Steinar Lundgren. Their work appears in journals such as European Journal of Cancer, The Journal of Steroid Biochemistry and Molecular Biology, Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.